Nobel Prize Honors Groundbreaking Body's Defenses Research

The prestigious award in Physiology or Medicine was awarded for transformative discoveries that illuminate how the immune system attacks dangerous pathogens while sparing the healthy tissues.

A trio of renowned researchers—from Japan Shimon Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—received this accolade.

Their research uncovered unique "sentinels" within the immune system that eliminate rogue defense cells that could harming the organism.

The discoveries are now paving the way for innovative treatments for immune disorders and malignancies.

The laureates will share a monetary award worth 11 million SEK.

Decisive Discoveries

"The work has been essential for understanding how the body's defenses operates and the reason we do not all suffer from severe autoimmune diseases," stated the chair of the award panel.

The team's studies explain a core question: How does the immune system defend us from countless infections while keeping our own tissues intact?

Our body's protection system uses immune cells that scan for indicators of infection, including viruses and bacteria it has not met before.

Such defenders utilize sensors—known as receptors—that are generated by chance in countless combinations.

That provides the immune system the capacity to fight a broad range of threats, but the unpredictability of the process inevitably creates white blood cells that may target the host.

Protectors of the Body

Scientists previously knew that some of these problematic defense cells were eliminated in the thymus—the site where white blood cells mature.

This year's Nobel Prize recognizes the identification of regulatory T-cells—described as the immune system's "peacekeepers"—which travel through the body to neutralize other defenders that attack the healthy cells.

It is known that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

The prize committee added, "These discoveries have laid the foundation for a new field of investigation and accelerated the creation of innovative treatments, for instance for cancer and autoimmune diseases."

Regarding cancer, regulatory T-cells prevent the system from attacking the growth, so studies are aimed at reducing their quantity.

In autoimmune diseases, experiments are testing increasing T-reg cells so the organism is no longer under attack. A comparable method could also be useful in reducing the risks of organ transplant failure.

Innovative Experiments

Professor Shimon Sakaguchi, of a Japanese institution, conducted tests on rodents that had their thymus removed, causing autoimmune disease.

He demonstrated that injecting immune cells from healthy animals could stop the disease—suggesting there was a system for blocking defenders from harming the host.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an genetic autoimmune disease in mice and humans that led to the identification of a gene critical for how T-regs operate.

"Their pioneering research has revealed how the immune system is kept in check by regulatory T cells, stopping it from mistakenly targeting the body's own tissues," said a prominent biological science specialist.

"The work is a remarkable illustration of how fundamental biological research can have broad consequences for human health."